Immunohistochemical analysis of Caspase-3 protein was consistent with the above, suggesting that FZYX attenuated cardiac remodelling after MI in rats by inhibiting apoptosis (Figure 7C). This evidence concerns the gene CASP3 and myocardial infarction.